Atossa Therapeutics Inc (ATOS)
1.46
-0.04
(-2.67%)
USD |
NASDAQ |
Apr 25, 10:34
Atossa Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2013 | -283.2% |
| September 30, 2013 | 66.14% |
| June 30, 2013 | 31.87% |
| March 31, 2013 | 63.62% |
| December 31, 2012 | 94.15% |
| Date | Value |
|---|---|
| September 30, 2012 | 85.72% |
| June 30, 2012 | 92.03% |
| March 31, 2012 | 50.64% |
| December 31, 2011 | -6.38K% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AngioDynamics Inc | 47.70% |
| Biolase Inc | 26.12% |
| Outset Medical Inc | 25.28% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 77.03% |